ArticleImmuno-oncology technology2025
Thromboembolism in patients with melanoma receiving immune checkpoint inhibitors: incidence and risk factors.
D C H van Dorst et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it